BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 11675415)

  • 1. Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy.
    Wang SN; Lapage J; Hirschberg R
    J Am Soc Nephrol; 2001 Nov; 12(11):2392-2399. PubMed ID: 11675415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy.
    Wang SN; LaPage J; Hirschberg R
    Kidney Int; 2000 Mar; 57(3):1002-14. PubMed ID: 10720953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy.
    Wang S; Denichilo M; Brubaker C; Hirschberg R
    Kidney Int; 2001 Jul; 60(1):96-105. PubMed ID: 11422741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SCUBE1-enhanced bone morphogenetic protein signaling protects against renal ischemia-reperfusion injury.
    Liao WJ; Lin H; Cheng CF; Ka SM; Chen A; Yang RB
    Biochim Biophys Acta Mol Basis Dis; 2019 Feb; 1865(2):329-338. PubMed ID: 30414502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTGF inhibits BMP-7 signaling in diabetic nephropathy.
    Nguyen TQ; Roestenberg P; van Nieuwenhoven FA; Bovenschen N; Li Z; Xu L; Oliver N; Aten J; Joles JA; Vial C; Brandan E; Lyons KM; Goldschmeding R
    J Am Soc Nephrol; 2008 Nov; 19(11):2098-107. PubMed ID: 18632843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BMP7 antagonizes TGF-beta -dependent fibrogenesis in mesangial cells.
    Wang S; Hirschberg R
    Am J Physiol Renal Physiol; 2003 May; 284(5):F1006-13. PubMed ID: 12676736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BMP7 is a podocyte survival factor and rescues podocytes from diabetic injury.
    Mitu GM; Wang S; Hirschberg R
    Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1641-8. PubMed ID: 17804487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of gremlin, a bone morphogenetic protein antagonist, in human diabetic nephropathy.
    Dolan V; Murphy M; Sadlier D; Lappin D; Doran P; Godson C; Martin F; O'Meara Y; Schmid H; Henger A; Kretzler M; Droguett A; Mezzano S; Brady HR
    Am J Kidney Dis; 2005 Jun; 45(6):1034-9. PubMed ID: 15957132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of gremlin, a bone morphogenetic protein antagonist, in glomerular crescents of pauci-immune glomerulonephritis.
    Mezzano S; Droguett A; Burgos ME; Aros C; Ardiles L; Flores C; Carpio D; Carvajal G; Ruiz-Ortega M; Egido J
    Nephrol Dial Transplant; 2007 Jul; 22(7):1882-90. PubMed ID: 17403698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone morphogenetic protein-7 signals opposing transforming growth factor beta in mesangial cells.
    Wang S; Hirschberg R
    J Biol Chem; 2004 May; 279(22):23200-6. PubMed ID: 15047707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth factor ultrafiltration in experimental diabetic nephropathy contributes to interstitial fibrosis.
    Wang SN; Hirschberg R
    Am J Physiol Renal Physiol; 2000 Apr; 278(4):F554-60. PubMed ID: 10751215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albumin up-regulates the type II transforming growth factor-beta receptor in cultured proximal tubular cells.
    Wolf G; Schroeder R; Ziyadeh FN; Stahl RA
    Kidney Int; 2004 Nov; 66(5):1849-58. PubMed ID: 15496155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone morphogenetic protein-7 attenuates pancreatic damage under diabetic conditions and prevents progression to diabetic nephropathy via inhibition of ferroptosis.
    Song SH; Han D; Park K; Um JE; Kim S; Ku M; Yang J; Yoo TH; Yook JI; Kim NH; Kim HS
    Front Endocrinol (Lausanne); 2023; 14():1172199. PubMed ID: 37293506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis.
    Sugimoto H; LeBleu VS; Bosukonda D; Keck P; Taduri G; Bechtel W; Okada H; Carlson W; Bey P; Rusckowski M; Tampe B; Tampe D; Kanasaki K; Zeisberg M; Kalluri R
    Nat Med; 2012 Feb; 18(3):396-404. PubMed ID: 22306733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2.
    Macías-Silva M; Hoodless PA; Tang SJ; Buchwald M; Wrana JL
    J Biol Chem; 1998 Oct; 273(40):25628-36. PubMed ID: 9748228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gremlin-mediated decrease in bone morphogenetic protein signaling promotes pulmonary fibrosis.
    Myllärniemi M; Lindholm P; Ryynänen MJ; Kliment CR; Salmenkivi K; Keski-Oja J; Kinnula VL; Oury TD; Koli K
    Am J Respir Crit Care Med; 2008 Feb; 177(3):321-9. PubMed ID: 17975199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMP-7 enhances SnoN mRNA expression in renal tubular epithelial cells under high-glucose conditions.
    Wang Y; Xiao Y; Li S; Shi L; Liu L; Zhang Y; Shi M; Guo B
    Mol Med Rep; 2017 Sep; 16(3):3308-3314. PubMed ID: 28765970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transfection of recombinant bone morphogenetic protein-7 expressing plasmid into cultured human renal tubular epithelial cells attenuates the extracellular matrix accumulation induced by transforming growth factor-beta].
    Li Y; Chen N; Yu HJ; Dong XP; Huang QH
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):544-8. PubMed ID: 16681885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal bone morphogenetic protein-7 protects against diabetic nephropathy.
    Wang S; de Caestecker M; Kopp J; Mitu G; Lapage J; Hirschberg R
    J Am Soc Nephrol; 2006 Sep; 17(9):2504-12. PubMed ID: 16899516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.